Majority of ICR Scientists Say Pandemic is Making Trial Enrollment Impossible
Sixty percent of respondents to an Institute of Cancer Research, London (ICR) survey said the pandemic has made it impossible to enroll patients in their trials.
Almost half of the 239 survey respondents said the pandemic in particular impacted their ability to access clinical samples needed for trials and lab experiments.
Approximately 36 percent of respondents to the survey said the pandemic had a “moderate” impact on their research, and an additional 36 percent of scientists said COVID-19 had a “substantial” impact. About 5 percent said the pandemic had an “extreme” impact on their work.